On October 10, 2025, IGC Pharma, Inc. held its Annual Meeting where stockholders elected two directors, ratified an accounting firm, approved a 5 million share grant, and increased authorized shares from 150 million to 600 million. Approximately 59.22% of shares voted, with majority support for all proposals.